You have 9 free searches left this month | for more free features.

recurrent small intestine cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +23 more
  • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy

Not yet recruiting
  • Small Intestine Disease
  • +5 more
    • (no location specified)
    Jan 30, 2023

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

    Not yet recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +2 more
    • Cetuximab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 2, 2023

    NSCLC Trial in Seoul (Lazertinib/Pemetrexed/Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 23, 2023

    NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +32 more
    • (no location specified)
    Mar 30, 2023

    Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

    Not yet recruiting
    • Recurrent Extensive Stage Small Cell Lung Carcinoma
    • Hangzhou, China
    • +2 more
    Feb 5, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • (no location specified)
    Jan 9, 2023

    Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Apr 21, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +4 more
      • Adenosine A2B Receptor Antagonist PBF-1129
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Feb 1, 2023

      Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

      Not yet recruiting
      • Recurrent Lung Non-Small Cell Carcinoma
      • Stage IV Lung Cancer AJCC v8
      • Biospecimen Collection
      • +5 more
      • (no location specified)
      Sep 7, 2023

      Carcinomas, Cervix Cancer, Cervical Cancer Trial in Houston (AK104)

      Recruiting
      • Carcinomas
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 12, 2022

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

      Recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +3 more
      • Biopsy
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 9, 2023

      Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

      Not yet recruiting
      • Recurrent Chronic Lymphocytic Leukemia
      • +3 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 10, 2023

      Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle

      Not yet recruiting
      • Metastatic Lung Non-Small Cell Carcinoma
      • +2 more
      • Atezolizumab
      • +6 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 6, 2023

      Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Platinum-Resistant Lung Small Cell Carcinoma

      Recruiting
      • Extensive Stage Lung Small Cell Carcinoma
      • +3 more
      • Biopsy
      • +4 more
      • Los Angeles, California
      • +8 more
      Jan 31, 2023

      Extensive Stage Small Cell Lung Carcinoma, Lung Adenocarcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in Scottsdale,

      Recruiting
      • Extensive Stage Small Cell Lung Carcinoma
      • +7 more
      • Scottsdale, Arizona
      • +1 more
      Jun 27, 2022

      NSCLC (Non-small-cell Lung Cancer) Trial in Changchun (Sintilimab, IBI310)

      Recruiting
      • NSCLC (Non-small-cell Lung Cancer)
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Sep 21, 2022

      EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

      Recruiting
      • EGFR Exon 20 Mutation
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 12, 2022

      Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

      Completed
      • Adult Grade III Lymphomatoid Granulomatosis
      • +88 more
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Apr 14, 2021

      Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)

      Recruiting
      • Extensive-stage Small Cell Lung Cancer
      • Tianjin, China
        Tianjin Medical University Cancer Institute and Hospital
      Jul 27, 2023

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

      Not yet recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • TQB3909 tablet
      • Zhengzhou, Henan, China
      • +1 more
      Jul 17, 2023

      Extensive Stage Lung Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in

      Recruiting
      • Extensive Stage Lung Small Cell Carcinoma
      • +5 more
      • Indianapolis, Indiana
      • +2 more
      Oct 26, 2022